BRIVARACETAM TEVA 25 mg, film-coated tablet 56 tablets
Active ingredients: BRIVARACÉTAM
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet56 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BRIVARACETAM TEVA 25 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC (ACLAR) polytrifluorochloroéthylène PVC-Aluminium de 56 comprimé(s)
- Marketing authorisation holder
- TEVA (PAYS-BAS)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 Aug 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64323258CIP73031776CIP133400930317761Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BRIVARACÉTAMcomprimé | 25 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: BRIVARACETAM 25 mg - BRIVIACT 25 mg, comprimé pelliculé